Biopharmaceutical manufacturing rarely stands still. As processes progress from development to clinical and commercial production, facilities must accommodate different products, campaign sizes and operating models. Manufacturers also face pressure to reduce downtime, control contamination risk and simplify operations without compromising chromatographic performance.

As manufacturing strategies evolve, the same facility may need to support different products, production scales and campaign schedules. This makes adaptability in column preparation an important consideration, alongside chromatographic performance.

The chromatography column is more than a container for resin. How it is packed, qualified and prepared for use can affect manufacturing schedules, specialist labour requirements and the resources available for other downstream activities.

The key consideration is how best to prepare chromatography columns for manufacturing whether through in-house packing or by using pre-packed, qualified columns. Both approaches offer distinct advantages, depending on the needs of the process and the manufacturing environment.

The hidden burden around chromatography

Packed-bed chromatography remains central to downstream bioprocessing, but the chromatography step encompasses considerably more than the separation itself.

In-house packing requires trained operators, suitable equipment and space, packing-method development, bed testing and documentation. An unsuccessful pack can lead to repacking and retesting, with consequences for manufacturing readiness.

For manufacturers with established packing capability, self-packing can provide valuable control over schedules, packing methods and hardware – if everything goes to right-first-time. For facilities managing multiple products or with constrained specialist resources, transferring packing to a qualified supplier can remove a significant operational task.

The choice is therefore about where column preparation takes place, not an assumption about how many times a column or its chromatography media will be used.

That choice can also evolve over a product lifecycle. In-house packing may be valuable during process development and optimization, while pre-packed columns can help reduce preparation demands as manufacturing schedules become more defined. Manufacturers with established packing capabilities may equally choose to continue self-packing at commercial scale.

One platform, two approaches to column packing

Column preparation can be managed in different ways depending on the needs of the process and the capabilities of the manufacturing facility. Some manufacturers prefer to retain packing and qualification in-house, particularly where established equipment, expertise and procedures are already in place. Others may benefit from using pre-packed columns, reducing the time and resources required for preparation before manufacturing.

The Evolve® platform accommodates both approaches, Evolve® Process columns are designed for self-packing, while Evolve®D columns are supplied pre-packed and qualified by Astrea Bioseparations. Both are available across a range of process-scale dimensions and share the same flow-path design, providing continuity in column technology regardless of the packing approach. The two approaches are not opposing technologies: they are complementary options within a familiar platform.

Resin selection remains an important consideration, Evolve®D columns can be supplied with Astrea Bioseparations chromatography media or customer-selected third-party resins, allowing manufacturers to retain their chosen separation chemistry while changing how the column is prepared.

Pre-packed columns: moving preparation beyond the manufacturing suite

Column packing is a specialist activity - a homogeneous, stable packed bed is essential for reliable chromatographic performance, and packing quality must be demonstrated before use. For manufacturers choosing Evolve®D, Astrea Bioseparations undertakes column packing and testing before delivery rather than leaving those activities to the manufacturing team.

Evolve®D columns are packed in ISO 7 cleanroom environments and supplied with a Certificate of Analysis and Regulatory Support File. Packed-bed performance is assessed through measures including efficiency, asymmetry and pressure-flow characteristics, supported by quality documentation. This approach can reduce the demand on internal packing facilities and specialist personnel, improve predictability of column preparation and help teams plan around manufacturing campaigns. The value is not simply convenience: it is the opportunity to make column readiness a supplied and documented part of the process.

Astrea Bioseparations can pack customer-specified media as well as its own resins, applying resin-specific packing expertise across a broad range of commercial chromatography media. For customers with an established resin selection, the packing approach can change without necessarily changing the separation medium.

Self-pack when operational control matters

Self-packing remains a choice for organizations with the equipment, expertise and processes to manage column preparation internally. Evolve® Process provides the hardware to support that approach, allowing users to control packing and qualification within their own operations.

Where changeover and cleaning of product-contact components are concerns, optional Evolve® Refresh Kits allow wetted flow-path components to be replaced while retaining the principal column hardware. This may reduce the cleaning and cleaning-validation burden between campaigns, subject to the manufacturer’s own process and quality requirements.

In multiproduct facilities, cleaning and changeover activities can affect equipment availability and production scheduling. The ability to replace wetted components offers an additional way to manage these activities where appropriate, without making reuse or disposal the defining feature of the column platform.

Refresh Kits are an additional capability within the self-pack offering, not a separate choice between “reusable” and “disposable” column categories. Decisions about column reuse, component replacement and resin reuse depend on the application and validated operating strategy.

Flexibility that starts with the flow path

Evolve® columns use a non-metallic process flow path, supporting compatibility with demanding process solutions, including high-salt buffers and guanidine hydrochloride, while avoiding corrosion in wetted flow areas.

The platform also accommodates a broad range of chromatography resins rather than requiring a single proprietary medium. This gives developers freedom to optimize the separation around the molecule and process requirements.

Scale without changing the fundamental platform

Scale-up is a consequential transition in bioprocess development. As a process moves toward manufacturing, changes in column size should not force unnecessary changes in operating philosophy.

Evolve® Process and Evolve®D cover corresponding process-scale diameters from 70 mm to 600 mm. Their shared flow-path design offers continuity whether a manufacturer chooses to self-pack or receive a pre-packed column. The platform supports the possibility of changing packing approach as facility needs, resources and campaign requirements evolve.

This continuity is especially valuable when requirements change between development, clinical and commercial manufacturing. Customers can reassess where packing is performed without necessarily changing their selected chromatography medium or underlying column platform.

Confidence in packing, qualification and supply

The pre-packed proposition is supported by more than column hardware. Astrea Bioseparations provides specialist packing capability, quality testing and documentation, with cleanroom packing operations in the UK and USA. Transport testing described in the commercial deck demonstrates packed-bed performance after simulated shipping for tested Evolve®D formats.

For high-value chromatography media, Evolve®D also incorporates a removable upper endplate designed to support ≥99% resin recovery. Resin recovery and any subsequent reuse remain subject to the suitability and evaluation of the recovered media for the intended process.

Choosing the approach that creates value

There is no universally correct approach to column packing. A manufacturer with an established packing suite may favour self-pack columns for direct control and flexibility. A multiproduct facility, CDMO or team facing tight campaign schedules may place greater value on receiving a pre-packed, tested and documented column.

These requirements can change over a product lifecycle. The strength of the Evolve® platform is the ability to support both approaches, with compatible design principles, resin choice and process-scale options.

Why Evolve®?

As biopharmaceutical manufacturing becomes more diverse and operationally demanding, chromatography flexibility must extend beyond dimensions and performance specifications. It also includes how columns are packed, qualified and made available for manufacturing.

Evolve® Process gives manufacturers a self-pack option, supported by replaceable wetted components where appropriate. Evolve®D puts Astrea Bioseparations’ packing expertise to work for customers seeking pre-packed, qualified columns ready for integration into their process.

The value of Evolve® lies in combining scalable column technology with flexibility in column preparation: customers can retain control through self-packing or draw on Astrea Bioseparations’ expertise for pre-packed, qualified columns, while working within a common platform that supports their evolving process needs.